Repligen Stock Analysis
RGEN Stock | USD 167.86 3.42 2.00% |
Repligen is fairly valued with Real Value of 163.31 and Target Price of 200.73. The main objective of Repligen stock analysis is to determine its intrinsic value, which is an estimate of what Repligen is worth, separate from its market price. There are two main types of Repligen's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Repligen's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Repligen's stock to identify patterns and trends that may indicate its future price movements.
The Repligen stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Repligen is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Repligen Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Repligen's ongoing operational relationships across important fundamental and technical indicators.
Repligen |
Repligen Stock Analysis Notes
About 93.0% of the company shares are owned by institutional investors. The book value of Repligen was at this time reported as 35.35. The company has Price/Earnings To Growth (PEG) ratio of 2.59. Repligen last dividend was issued on the 29th of October 2010. Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts. Repligen operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 1852 people. To find out more about Repligen contact Anthony Hunt at 781 250 0111 or learn more at https://www.repligen.com.Repligen Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Repligen's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Repligen or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Repligen generated a negative expected return over the last 90 days | |
Repligen is unlikely to experience financial distress in the next 2 years | |
Repligen has a strong financial position based on the latest SEC filings | |
Over 93.0% of the company shares are owned by institutional investors | |
Latest headline from finance.yahoo.com: Should be Confident in Repligen Corporation s Long-Term Growth Potential |
Repligen Upcoming and Recent Events
Earnings reports are used by Repligen to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Repligen previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
28th of February 2024 Upcoming Quarterly Report | View | |
7th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
28th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Repligen Largest EPS Surprises
Earnings surprises can significantly impact Repligen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2017-02-22 | 2016-12-31 | 0.07 | 0.08 | 0.01 | 14 | ||
2010-06-09 | 2010-03-31 | -0.04 | -0.05 | -0.01 | 25 | ||
2009-11-05 | 2009-09-30 | -0.04 | -0.03 | 0.01 | 25 |
Repligen Thematic Classifications
In addition to having Repligen stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Office SuppliesOffice products, supplies, and accessories | ||
Health ManagementHealthcare providers, hospitals |
Repligen Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Repligen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Repligen backward and forwards among themselves. Repligen's institutional investor refers to the entity that pools money to purchase Repligen's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Wellington Management Company Llp | 2023-12-31 | 1.1 M | Impax Asset Management Group Plc | 2023-09-30 | 972.7 K | Champlain Investment Partners, Llc | 2023-12-31 | 926.4 K | William Blair Investment Management, Llc | 2023-12-31 | 905.8 K | Geode Capital Management, Llc | 2023-09-30 | 852.2 K | Amvescap Plc. | 2023-12-31 | 833.1 K | Alliancebernstein L.p. | 2023-09-30 | 785.1 K | Harding Loevner L.p. | 2023-12-31 | 716.3 K | Conestoga Capital Advisors, Llc | 2023-12-31 | 709.7 K | Blackrock Inc | 2023-12-31 | 7.9 M | Vanguard Group Inc | 2023-09-30 | 5 M |
Repligen Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.56 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Repligen's market, we take the total number of its shares issued and multiply it by Repligen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Repligen Profitablity
Repligen's profitability indicators refer to fundamental financial ratios that showcase Repligen's ability to generate income relative to its revenue or operating costs. If, let's say, Repligen is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Repligen's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Repligen's profitability requires more research than a typical breakdown of Repligen's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.05 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.05. Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.03 | 0.03 | |
Return On Capital Employed | 0.02 | 0.02 | |
Return On Assets | 0.01 | 0.02 | |
Return On Equity | 0.02 | 0.02 |
Management Efficiency
Repligen has return on total asset (ROA) of 0.0131 % which means that it generated a profit of $0.0131 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0214 %, meaning that it created $0.0214 on every $100 dollars invested by stockholders. Repligen's management efficiency ratios could be used to measure how well Repligen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of April 2024, Return On Tangible Assets is likely to grow to 0.03. Also, Return On Capital Employed is likely to grow to 0.02. At this time, Repligen's Intangible Assets are very stable compared to the past year. As of the 25th of April 2024, Net Tangible Assets is likely to grow to about 847.1 M, while Deferred Long Term Asset Charges is likely to drop about 2.2 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 35.38 | 37.15 | |
Net Current Asset Value | 0.00 | 0.00 | |
Tangible Asset Value | 0.00 | 0.00 | |
Tangible Book Value Per Share | 10.47 | 11.00 | |
Enterprise Value Over EBITDA | 75.95 | 79.75 | |
Price Book Value Ratio | 5.08 | 4.83 | |
Enterprise Value Multiple | 75.95 | 79.75 | |
Price Fair Value | 5.08 | 4.83 | |
Enterprise Value | 12.9 B | 13.5 B |
The analysis of Repligen's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Repligen's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Repligen Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 1.006 |
Technical Drivers
As of the 25th of April, Repligen holds the Variance of 5.48, coefficient of variation of (7,393), and Risk Adjusted Performance of (0). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Repligen, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to analyze and collect data for thirteen technical drivers for Repligen, which can be compared to its competitors. Please check Repligen market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Repligen is priced some-what accurately, providing market reflects its current price of 167.86 per share. Given that Repligen has information ratio of (0.05), we recommend you to check out Repligen's recent market performance to make sure the company can sustain itself at a future point.Repligen Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Repligen middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Repligen. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Repligen Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Repligen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Repligen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Repligen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
James Bylund over three weeks ago Disposition of 444 shares by James Bylund of Repligen at 182.95 subject to Rule 16b-3 | ||
Ralf Kuriyel over a month ago Acquisition by Ralf Kuriyel of 1271 shares of Repligen at 86.1 subject to Rule 16b-3 | ||
Christine Gebski over a month ago Disposition of 386 shares by Christine Gebski of Repligen at 195.72 subject to Rule 16b-3 | ||
James Bylund over a month ago Disposition of tradable shares by James Bylund of Repligen at 195.52 subject to Rule 16b-3 | ||
James Bylund over a month ago Disposition of 820 shares by James Bylund of Repligen at 191.79 subject to Rule 16b-3 | ||
Jon Snodgres over six months ago Payment of 710 shares by Jon Snodgres of Repligen subject to Rule 16b-3 | ||
Jon Snodgres over a year ago Acquisition by Jon Snodgres of 4848 shares of Repligen subject to Rule 16b-3 | ||
Jon Snodgres over a year ago Payment of 521 shares by Jon Snodgres of Repligen subject to Rule 16b-3 | ||
Jon Snodgres over a year ago Payment of 682 shares by Jon Snodgres of Repligen subject to Rule 16b-3 |
Repligen Predictive Daily Indicators
Repligen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Repligen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 23823.38 | |||
Daily Balance Of Power | (0.45) | |||
Rate Of Daily Change | 0.98 | |||
Day Median Price | 169.7 | |||
Day Typical Price | 169.08 | |||
Price Action Indicator | (3.54) | |||
Period Momentum Indicator | (3.42) | |||
Relative Strength Index | 15.89 |
Repligen Corporate Filings
F4 | 4th of April 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
1st of April 2024 Other Reports | ViewVerify | |
F4 | 20th of March 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 19th of March 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 12th of March 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 11th of March 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 7th of March 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 6th of March 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Repligen Forecast Models
Repligen's time-series forecasting models are one of many Repligen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Repligen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Repligen Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Repligen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Repligen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Repligen. By using and applying Repligen Stock analysis, traders can create a robust methodology for identifying Repligen entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | 0.10 | 0.11 | |
Operating Profit Margin | 0.1 | 0.10 | |
Net Profit Margin | 0.07 | 0.07 | |
Gross Profit Margin | 0.44 | 0.50 |
Current Repligen Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Repligen analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Repligen analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
200.73 | Strong Buy | 12 | Odds |
Most Repligen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Repligen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Repligen, talking to its executives and customers, or listening to Repligen conference calls.
Repligen Stock Analysis Indicators
Repligen stock analysis indicators help investors evaluate how Repligen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Repligen shares will generate the highest return on investment. By understating and applying Repligen stock analysis, traders can identify Repligen position entry and exit signals to maximize returns.
Begin Period Cash Flow | 523.5 M | |
Total Stockholder Equity | 2 B | |
Capital Lease Obligations | 132.2 M | |
Property Plant And Equipment Net | 323 M | |
Cash And Short Term Investments | 751.3 M | |
Cash | 751.3 M | |
50 Day M A | 186.8568 | |
Net Interest Income | -2.9 M | |
Total Current Liabilities | 158.2 M | |
Forward Price Earnings | 119.0476 | |
Investments | -74.7 M | |
Interest Expense | 10 M | |
Stock Based Compensation | 25.6 M | |
Long Term Debt | 510.1 M | |
Common Stock Shares Outstanding | 56.4 M | |
Tax Provision | 10.1 M | |
Quarterly Earnings Growth Y O Y | -0.549 | |
Accounts Payable | 19.6 M | |
Net Debt | -39.5 M | |
Other Operating Expenses | 575.5 M | |
Non Current Assets Total | 1.7 B | |
Liabilities And Stockholders Equity | 2.8 B | |
Non Currrent Assets Other | 1.3 M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.Note that the Repligen information on this page should be used as a complementary analysis to other Repligen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for Repligen Stock analysis
When running Repligen's price analysis, check to measure Repligen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repligen is operating at the current time. Most of Repligen's value examination focuses on studying past and present price action to predict the probability of Repligen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repligen's price. Additionally, you may evaluate how the addition of Repligen to your portfolios can decrease your overall portfolio volatility.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Is Repligen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.55) | Earnings Share 0.74 | Revenue Per Share 11.464 | Quarterly Revenue Growth (0.17) | Return On Assets 0.0131 |
The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.